New York, May 12, 2026, 13:04 (ET)
- Rocket Lab was last seen at $114.58 just after 12:49 p.m. ET, down 2.4%. Shares moved sharply, ranging from $111.19 to $121.34 earlier in the session.
- Still running on last week’s earnings surprise—record revenue, a $2.2 billion backlog in hand, plus more launch contracts signed during Q1 than the company managed for all of 2025.
- Bulls argue Neutron and growing defense demand are driving future sales into the present, while skeptics point to a company with nearly $70 billion in market cap that’s still running at a loss.
Rocket Lab shares pulled back on Tuesday, giving back some ground after their sharp climb to new highs. The action didn’t point to a big shift in sentiment—buyers continued snapping up shares on weakness, even as some holders locked in gains after the post-earnings surge. Both sides stayed active, but the day’s drop looked more like a pause than a reversal in RKLB’s trajectory.
That’s what pushed the chart—nothing to do with investors suddenly ignoring last quarter. The numbers from last week triggered a quick re-pricing, and after that kind of vertical surge, the stock hit a wall: price needed evidence, not just hype. RKLB notched a record high at $123.94 on Monday, Benzinga noted, and with a near 40% rally logged over the week, some investors took the chance to cash out on Tuesday’s open, leading to early weakness.
Bulls had plenty to chew on after Rocket Lab’s latest results. First-quarter revenue landed at $200.3 million, a jump of 63.5% from last year. The company expects second-quarter revenue between $225 million and $240 million. Their backlog—contracts signed but not yet recognized as revenue—reached $2.2 billion, marking a 20.2% increase from the previous quarter.
The real headline wasn’t just a revenue beat. It was the way orders came in. Rocket Lab reported 31 Electron and HASTE contracts plus five dedicated Neutron launches locked up in Q1. That’s more launches sold in three months than the entire haul for 2025. The question now isn’t about demand—it’s whether Rocket Lab can deliver on pace.
On the call, management hammered home the point. Chief executive Peter Beck pointed to the fresh five-launch Neutron order—calling it the biggest contract in the company’s history—and brushed off any concerns about future demand. “Neutron demand is not one of them,” he said flatly. Chief financial officer Adam Spice took a different angle, flagging that cash burn will remain high as Rocket Lab pours money into Neutron’s development, procurement, and scaling up production. The Motley Fool
The bull thesis is straightforward and only getting more convincing. Rocket Lab isn’t just a small-launch player anymore. The company’s roster now includes launch services, satellite hardware, full spacecraft assembly, hypersonic testing contracts, and a medium-lift rocket that’s stepping into the same territory still held by SpaceX’s Falcon 9. Price targets are moving higher: Needham’s Ryan Koontz bumped his up to $120 from $95, while Deutsche Bank went to $120 from $73. The Fly flagged Deutsche’s note calling demand “rising all around.” Benzinga
The downside argument is straightforward. Rocket Lab, trading around $114 per share, sits at roughly $69.5 billion in market cap, yet its price-to-earnings ratio is still negative. That’s simply the share price divided by earnings per share—a negative figure here signals Rocket Lab hasn’t reached profitability. Investors aren’t betting on current earnings. What’s moving the stock is belief that Neutron will deliver—launching as planned and reworking the company’s profit margins.
Cash flow tells the story here. Rocket Lab burned through $77.4 million in non-GAAP free cash flow during Q1—free cash flow meaning what’s left after operating cash and capital expenditures are subtracted. Liquidity isn’t the issue. But adjusted EBITDA, which strips out interest, taxes, depreciation and more, is still projected negative for Q2. The company guides for a loss between $20 million and $26 million on that metric.
The broader space sector wasn’t offering much support Tuesday. Shares of AST SpaceMobile tumbled 14.5%, Intuitive Machines slid 6.9%, and Redwire dipped 8.1% as of early afternoon. So RKLB’s gain isn’t riding a sector wave—investors are distinguishing Rocket Lab’s order haul from a sharp pullback in riskier space plays.
Prediction-market action captured just how fast sentiment extended. On Polymarket, a small weekly RKLB contract flashed a 100% implied probability the stock would touch $118 in the week of May 11. Volume? $12.4 thousand. But with RKLB already above that price, the market looked less like a live handicap and more like a lagging indicator, spotlighting how quickly buyers blew past previous targets.
The next hurdle for the stock is more straightforward than the current price swings suggest. Neutron still needs to stay on track for its late-2026 debut, defense contracts must actually generate revenue, and Space Systems has to take on incoming orders without putting margins at risk. Rocket Lab has handed investors a broader narrative, but Tuesday’s drop shows the market is starting to factor in what it’ll cost to deliver.
